- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Activos Clys SICAV SA
+ Add to WatchlistS0037:SM
1.12 EUR 0.000.00%As of 10:00:30 ET on 05/17/2013.
Snapshot for Activos Clys SICAV SA (S0037)
| Year To Date: | +5.25% | 3-Month: | +3.56% | 3-Year: | +3.51% | 52-Week Range: | 0.99 - 1.12 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +3.34% | 1-Year: | +11.67% | 5-Year: | +0.58% | Beta vs IBEX: | 0.49 |
Fund Profile & Information for S0037
Activos Clys SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 10-31-2006 | Telephone: | 34-93-404-7700 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.lacaixa.es | ||
Fundamentals for S0037
| NAV | (on 2013-05-17) 1.12 |
|---|---|
| Assets (M) | (on 2013-04-03) 3.43 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for S0037
No dividends reported
Fees & Expenses for S0037
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.70 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for S0037
Filing Date: 05/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Robeco Capital Growth - US Pre | 2,996 | 295,323 | 8.587% |
| Morgan Stanley Investment Fund | 10,476 | 231,250 | 6.724% |
| Allianz US Equity | 2,625 | 223,249 | 6.492% |
| BNY Mellon Global Funds plc - | 120,827 | 144,945 | 4.215% |
| PIMCO Funds Global Investors S | 12,133 | 143,649 | 4.177% |
| SABSM 4 ½ 02/11/13 | 100 | 100,986 | 2.936% |
| SANTAN 3 ¾ 02/28/13 | 100 | 99,946 | 2.906% |
| BBVASM 4 03/22/13 | 100 | 99,867 | 2.904% |
| FROB 4 ½ 02/03/14 | 100 | 98,333 | 2.859% |
| SPGB 3.4 04/30/14 | 100 | 97,405 | 2.832% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page